» Articles » PMID: 38874038

Prevalence and Causes of Vitamin D Deficiency in a Cohort of Greek HIV-Infected Individuals: A Prospective, Single Center, Observational Study

Overview
Journal Curr HIV Res
Date 2024 Jun 14
PMID 38874038
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitamin D deficiency and/or insufficiency (hypovitaminosis D) has been associated with several disorders including autoimmune diseases, like type 1 diabetes mellitus; cardiovascular diseases; neoplasms; obesity; insulin resistance, and type 2 diabetes mellitus. This problem is common in southern European countries, especially in elderly and institutionalized persons. In HIV-infected individuals, hypovitaminosis D has been correlated with various complications like tuberculosis, hyperparathyroidism, bone mass loss, premature atherosclerosis, and systemic arterial hypertension, deterioration of immune function, progression of the disease and overall mortality.

Objective: The objective of this study was to examine the prevalence and causes of hypovitaminosis D in a cohort of Greek HIV-infected patients, as well as possible complications associated with it.

Methods: All patients attending our HIV unit for a period of 5 months were included in this study. Vitamin D status, medical anamnes, and laboratory tests were obtained at baseline; patients were followed for 3 years and HIV-related complications were noted. No patient received vitamin D supplementation during the follow-up period.

Results: Hypovitaminosis D was common, with 83.7% of the patients showing levels below 30 ng/dl and 55.4% below 20 ng/dl. After multivariable analysis, age and duration of treatment were the only significant factors for low vitamin D levels. During follow-up, 26 patients exhibited a total of 34 HIV-related complications, the most common being pneumonocystis jiroveci pneumonia (PCP). Hypovitaminosis D showed a positive correlation with overall complications, PCP as well as wasting syndrome.

Conclusion: Overall, our study shows that hypovitaminosis D is common in HIV-infected individuals and should probably be treated as soon as possible to protect these patients from serious HIVrelated complications like PCP or wasting syndrome.

References
1.
Adams J, Hewison M . Update in vitamin D. J Clin Endocrinol Metab. 2010; 95(2):471-8. PMC: 2840860. DOI: 10.1210/jc.2009-1773. View

2.
Bikle D . Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2008; 94(1):26-34. PMC: 2630868. DOI: 10.1210/jc.2008-1454. View

3.
Oyedele T, Adeyemi O . High prevalence of vitamin D deficiency in HIV-infected adults: what are the future research questions?. Curr HIV/AIDS Rep. 2011; 9(1):1-4. DOI: 10.1007/s11904-011-0101-9. View

4.
Canuto J, Canuto V, de Lima M, Omena A, Melo de Lima Morais T, Paiva A . Risk factors associated with hypovitaminosis D in HIV/aids-infected adults. Arch Endocrinol Metab. 2015; 59(1):34-41. DOI: 10.1590/2359-3997000000007. View

5.
Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Tmava Berisha A . Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020; 74(11):1498-1513. PMC: 7091696. DOI: 10.1038/s41430-020-0558-y. View